Tirzepatide Once Weekly for the Treatment of Obesity
In this 72-week trial in participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight. (Supported by ...
Publications
2 shownAggregation‐Suppressed and Synergistically Anchored Co‐SAMs for High‐Efficiency Stable Perovskite Solar Cells
The interfacial properties of the hole transport layer (HTL) are absolutely critical for perovskite solar cells (PSCs) nowadays. [4‐(3,6‐Dimethyl‐9H‐carbazol‐9‐yl)butyl]phosphon...
Frequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 2
- Citations
- 2,460
- Institution
- Eli Lilly (United States)
External Links
Identifiers
- ORCID
- 0000-0003-1419-3635
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.